Twist Bioscience Corporation (TWST) Stock Analysis
A live, multi-source view of Twist Bioscience Corporation (TWST): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Twist Bioscience Corporation
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution.
Sector: Healthcare · Industry: Biotechnology · United States · 979 employees · twistbioscience.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Twist Bioscience Corporation (TWST) had a market capitalization of $7.82B (forward -196.9) and a beta of 2.22; the shares traded in a 52-week range of $23.30 – $155.44 (375.1% over the year).
- Market cap
- $7.82B
- Enterprise value
- $7.76B
- Forward P/E
- -196.9
- Price / book
- 17.54
- EPS (trailing)
- $-2.23
- EPS (forward)
- $-0.63
- Payout ratio
- 0.0%
- 52-week range
- $23.30 – $155.44
- 52-week change
- 375.1%
- Beta
- 2.22
- Average volume
- 1.8M
- Shares outstanding
- 62.7M
- Short % of float
- 27.08%
- Profit margin
- -31.7%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Twist Bioscience Corporation (TWST) last closed at $126.85 (the last completed close before that scan).
Technicals at the scan: RSI 51 (neutral territory), price -5.4% versus its 20-day average, 20-day versus 50-day average spread +19.2%, MACD histogram -3.34.
Sentiment inputs: 100% of recent Finnhub-scored headlines read bullish; StockTwits 64% bullish; analyst consensus score 69/100.
Next scheduled company event: in 66 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of TWST; corporate insiders filed 0 buys and 35 sells (8 distinct filers, latest disclosure 2026-09-10). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Emily M. Leproust (0B/10S), Patrick John Finn (0B/10S), Dennis Cho (0B/5S), Robert F. Werner (0B/4S), Paula Green (0B/3S), Adam Laponis (0B/1S). Who is trading what
RapidTradeView pick record
TWST has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Twist Bioscience Corporation (TWST) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell TWST.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.